ENDRA Life Sciences (NDRA) Short term Debt (2022 - 2023)
ENDRA Life Sciences (NDRA) reported Short term Debt of $28484.0 for Q4 2023, little changed year-over-year from $28484.0 in Q4 2022, and little changed quarter-over-quarter from $28484.0 in Q3 2023.
ENDRA Life Sciences (NDRA) Short term Debt (2022 - 2023) Analysis & Trends
ENDRA Life Sciences (NDRA) has 2 years of Short term Debt data on file, last reported at $28484.0 in Q4 2023.
- Short term Debt for Q4 2023 came in at $28484.0, changed 0.0% year-over-year; the trailing twelve-month figure through Dec 2023 was $28484.0 (changed 0.0% YoY), and the FY2023 annual result was $28484.0, changed 0.0% from the prior year.
- Short term Debt steadied at $28484.0 in Q4 2023 per NDRA's latest filing, from $28484.0 in the prior quarter.
- Over five years, Short term Debt peaked at $28484.0 in Q4 2022 and troughed at $28484.0 in Q4 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Waters | 29,902.70 Bn | 29,902.24 Bn | 1.11 Bn |
| 2 | Thermo Fisher Scientific | 175.99 Bn | 172.74 Bn | 7.74 Bn |
| 3 | Danaher | 129.87 Bn | 124.18 Bn | 3.59 Bn |
| 4 | Idexx Laboratories | 44.75 Bn | 44.55 Bn | 722.74 Mn |
| 5 | Agilent Technologies | 37.52 Bn | 35.72 Bn | 990.00 Mn |
| 6 | Iqvia Holdings | 30.91 Bn | 28.94 Bn | 1.36 Bn |
| 7 | Natera | 30.21 Bn | 29.11 Bn | 696.04 Mn |
| 8 | Illumina | 24.19 Bn | 23.04 Bn | 721.00 Mn |
| 9 | Mettler Toledo International | 23.12 Bn | 23.06 Bn | 555.82 Mn |
| 10 | ENDRA Life Sciences | 5.25 Mn | 4.90 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 28,484.00 |
| Sep 30, 2023 | 28,484.00 |
| Jun 30, 2023 | 28,484.00 |
| Dec 31, 2022 | 28,484.00 |